# Bronte Capital Management Pty Ltd.

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1471085. Source: https://holderbook.com/funds/1471085-bronte-capital-management-pty-ltd/

- Reported value: $931.1M
- Positions: 56
- Weight of the ten largest: 75.5%
- Filed: 2026-08-05

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $144.2M | 162,618 | 15.5% | 23 |
| ALPHABET INC | [GOOGL](https://holderbook.com/stocks/GOOGL/) | $109.1M | 305,165 | 11.7% | 31 |
| INTERACTIVE BROKERS GROUP IN | [IBKR](https://holderbook.com/stocks/IBKR/) | $76.9M | 883,526 | 8.3% | 31 |
| VISA INC-CLASS A SHARES | - | $75.5M | 219,914 | 8.1% | 12 |
| BERKSHIRE HATHAWAY INC DEL | [BRKB](https://holderbook.com/stocks/BRKB/) | $73.0M | 145,847 | 7.8% | 31 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $62.3M | 261,433 | 6.7% | 14 |
| PHILIP MORRIS INTL INC | [PM](https://holderbook.com/stocks/PM/) | $54.3M | 300,176 | 5.8% | 20 |
| CORTEVA INC | [CTVA](https://holderbook.com/stocks/CTVA/) | $38.7M | 456,656 | 4.2% | 28 |
| CAPITAL ONE FINL CORP | [COF](https://holderbook.com/stocks/COF/) | $34.8M | 173,523 | 3.7% | 5 |
| DISNEY WALT CO | [DIS](https://holderbook.com/stocks/DIS/) | $34.7M | 360,243 | 3.7% | 2 |
| FIRST CTZNS BANCSHARES INC D | [FCNCA](https://holderbook.com/stocks/FCNCA/) | $29.5M | 14,179 | 3.2% | 14 |
| BBB FOODS INC | [TBBB](https://holderbook.com/stocks/TBBB/) | $22.2M | 533,151 | 2.4% | 3 |
| AURORA INNOVATION INC | [AUR](https://holderbook.com/stocks/AUR/) | $14.9M | 2,186,821 | 1.6% | 2 |
| VANECK ETF TRUST | - | $14.5M | 191,580 | 1.6% | 12 |
| SOTERA HEALTH CO | - | $14.1M | 797,138 | 1.5% | 14 |
| NEKTAR THERAPEUTICS | [NKTR](https://holderbook.com/stocks/NKTR/) | $13.9M | 198,434 | 1.5% | 2 |
| GRAHAM HLDGS CO | [GHC](https://holderbook.com/stocks/GHC/) | $13.1M | 11,454 | 1.4% | 24 |
| ISHARES TR | [IBB](https://holderbook.com/stocks/IBB/) | $12.5M | 65,807 | 1.3% | 17 |
| BROWN FORMAN CORP | [BFB](https://holderbook.com/stocks/BFB/) | $12.4M | 464,313 | 1.3% | 1 |
| ALNYLAM PHARMACEUTICALS INC | [ALNY](https://holderbook.com/stocks/ALNY/) | $10.7M | 35,384 | 1.1% | 4 |
| SOCIEDAD QUIMICA Y MINERA DE | [SQM](https://holderbook.com/stocks/SQM/) | $8.6M | 116,308 | 0.9% | 19 |
| GLOBAL E ONLINE LTD | [GLBE](https://holderbook.com/stocks/GLBE/) | $7.9M | 227,644 | 0.8% | 2 |
| NEWMONT CORP | [NEM](https://holderbook.com/stocks/NEM/) | $6.5M | 69,494 | 0.7% | 5 |
| BARRICK MNG CORP | [B](https://holderbook.com/stocks/B/) | $5.4M | 146,359 | 0.6% | 5 |
| LIVERAMP HLDGS INC | [RAMP](https://holderbook.com/stocks/RAMP/) | $4.8M | 128,348 | 0.5% | 11 |
| HERBALIFE LTD | [HLF](https://holderbook.com/stocks/HLF/) | $4.3M | 323,386 | 0.5% | 31 |
| REVOLUTION MEDICINES INC | [RVMD](https://holderbook.com/stocks/RVMD/) | $3.5M | 18,780 | 0.4% | 1 |
| TURNING PT BRANDS INC | [TPB](https://holderbook.com/stocks/TPB/) | $3.5M | 40,721 | 0.4% | 3 |
| ISHARES TR | [IJR](https://holderbook.com/stocks/IJR/) | $3.4M | 23,004 | 0.4% | 1 |
| BATH & BODY WORKS INC | [BBWI](https://holderbook.com/stocks/BBWI/) | $3.3M | 143,800 | 0.4% | 20 |
| MONDELEZ INTL INC | [MDLZ](https://holderbook.com/stocks/MDLZ/) | $3.1M | 53,234 | 0.3% | 21 |
| RISKIFIED LTD | [RSKD](https://holderbook.com/stocks/RSKD/) | $3.0M | 588,251 | 0.3% | 16 |
| BROWN FORMAN CORP | [BFA](https://holderbook.com/stocks/BFA/) | $2.6M | 95,365 | 0.3% | 2 |
| TYLER TECHNOLOGIES INC | [TYL](https://holderbook.com/stocks/TYL/) | $2.4M | 8,302 | 0.3% | 1 |
| VANECK ETF TRUST | - | $2.4M | 24,568 | 0.3% | 12 |
| PAYLOCITY HLDG CORP | [PCTY](https://holderbook.com/stocks/PCTY/) | $1.9M | 17,874 | 0.2% | 2 |
| NICE LTD | [NICE](https://holderbook.com/stocks/NICE/) | $1.5M | 16,396 | 0.2% | 3 |
| UNIVERSAL DISPLAY CORP | [OLED](https://holderbook.com/stocks/OLED/) | $889.2K | 10,269 | 0.1% | 3 |
| VERISK ANALYTICS INC | [VRSK](https://holderbook.com/stocks/VRSK/) | $481.5K | 2,682 | 0.1% | 2 |
| ENOVIX CORPORATION | [ENVX](https://holderbook.com/stocks/ENVX/) | $92.9K | 41,765 | 0.0% | 4 |
| TREACE MED CONCEPTS INC | [TMCI](https://holderbook.com/stocks/TMCI/) | $62.0K | 15,577 | 0.0% | 1 |
| FATE THERAPEUTICS INC | [FATE](https://holderbook.com/stocks/FATE/) | $58.7K | 21,740 | 0.0% | 3 |
| AN2 THERAPEUTICS INC | [ANTX](https://holderbook.com/stocks/ANTX/) | $52.7K | 10,895 | 0.0% | 1 |
| C4 THERAPEUTICS INC | [CCCC](https://holderbook.com/stocks/CCCC/) | $48.3K | 10,349 | 0.0% | 3 |
| ALX ONCOLOGY HLDGS INC | [ALXO](https://holderbook.com/stocks/ALXO/) | $37.5K | 18,095 | 0.0% | 1 |
| BLEND LABS INC | [BLND](https://holderbook.com/stocks/BLND/) | $32.9K | 19,247 | 0.0% | 1 |
| PEPGEN INC | [PEPG](https://holderbook.com/stocks/PEPG/) | $32.0K | 17,776 | 0.0% | 1 |
| COMMERCE.COM INC | [CMRC](https://holderbook.com/stocks/CMRC/) | $30.4K | 10,278 | 0.0% | 1 |
| PACIFIC BIOSCIENCES CALIF IN | [PACB](https://holderbook.com/stocks/PACB/) | $30.0K | 17,881 | 0.0% | 1 |
| ACUMEN PHARMACEUTICALS INC | [ABOS](https://holderbook.com/stocks/ABOS/) | $28.6K | 10,716 | 0.0% | 1 |
| SEER INC | [SEER](https://holderbook.com/stocks/SEER/) | $25.1K | 15,109 | 0.0% | 1 |
| ALECTOR INC | [ALEC](https://holderbook.com/stocks/ALEC/) | $23.6K | 11,758 | 0.0% | 3 |
| NOVABRIDGE BIOSCIENCES | [NBP](https://holderbook.com/stocks/NBP/) | $21.8K | 11,192 | 0.0% | 1 |
| COHERUS ONCOLOGY INC | [CHRS](https://holderbook.com/stocks/CHRS/) | $21.4K | 15,262 | 0.0% | 3 |
| MILESTONE PHARMACEUTICALS IN | [MIST](https://holderbook.com/stocks/MIST/) | $19.3K | 14,390 | 0.0% | 3 |
| GOSSAMER BIO INC | [GOSS](https://holderbook.com/stocks/GOSS/) | $11.2K | 67,754 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +7.9% | +14.8% | -7.0% | 81% |
| Q1 2026 | -3.0% | -4.6% | +1.6% | 83% |
| Q4 2025 | +11.1% | +2.4% | +8.8% | 78% |
| Q3 2025 | +8.2% | +7.8% | +0.3% | 79% |
| Q2 2025 | +6.0% | +10.5% | -4.5% | 77% |
| Q1 2025 | -2.6% | -4.6% | +1.9% | 78% |
| Q4 2024 | +1.3% | +2.1% | -0.8% | 91% |
| Q3 2024 | +2.8% | +5.4% | -2.6% | 88% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $931.1M | 56 |
| Q1 2026 | $1.0B | 51 |
| Q4 2025 | $1.0B | 43 |
| Q3 2025 | $1.1B | 30 |
| Q2 2025 | $1.3B | 27 |
| Q1 2025 | $1.2B | 26 |
| Q4 2024 | $1.3B | 24 |
| Q3 2024 | $1.2B | 25 |
| Q2 2024 | $1.3B | 28 |
| Q1 2024 | $1.2B | 30 |
| Q4 2023 | $1.1B | 30 |
| Q3 2023 | $992.8M | 28 |